PD-1 and CSF-1R blockade in combination was also found to augment the cytolytic capacity of tumor infiltrating lymphocytes (TILs) in co-cultures of CD3+ TILs and CD11b+ tumor infiltrating myeloid cells from patients with glioblastoma (64). Here, CSF1R is linked to glioblastoma.